
Relapsed or refractory primary mediastinal B-cell lymphoma Program in Pharmaceutical Benefits Scheme (PBS) 012-20082617

-   Background
-   Process
-   Resources

[Expand/Collapse all sections]Expand all

For information on how to process a PBS Authority, see Processing
Written Authority Required Listings. Contact a Program Support Officer
(PSO) if unsure on how to action an application.

Relapsed or refractory primary mediastinal B-cell lymphoma quick reference

+-----------+-----------+-----------+-----------+-----------+-----------+
| Res       | Authority | PA        | P         | P         | P         |
| trictions | level and | a         | rocessing | rescriber | rescriber |
|           | section   | ssessment | system    | type      | s         |
|           |           |           |           |           | elf-serve |
+-----------+-----------+-----------+-----------+-----------+-----------+
| Initial   | Written   | No        | OPA       | N/A       | Yes       |
|           |           |           |           |           |           |
| PB296     | E         |           |           |           |           |
| form      | lectronic |           |           |           |           |
|           |           |           |           |           |           |
|           | S100 EFC: |           |           |           |           |
|           |           |           |           |           |           |
|           | pemb      |           |           |           |           |
|           | rolizumab |           |           |           |           |
+-----------+-----------+-----------+-----------+-----------+-----------+
| C         | Telephone | No        | OPA       | N/A       | Yes       |
| ontinuing |           |           |           |           |           |
|           | E         |           |           |           |           |
|           | lectronic |           |           |           |           |
|           |           |           |           |           |           |
|           | S100 EFC: |           |           |           |           |
|           |           |           |           |           |           |
|           | pemb      |           |           |           |           |
|           | rolizumab |           |           |           |           |
+-----------+-----------+-----------+-----------+-----------+-----------+

                                   

-   Services Australia ABN 90 794 605 008 
